The addition of prazosin to standard triple therapy in the treatment of severe hypertension.
- 1 April 1982
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 13 (4) , 539-541
- https://doi.org/10.1111/j.1365-2125.1982.tb01418.x
Abstract
1 A small dose of prazosin was added to the treatment regime of sixteen hypertensive patients poorly controlled on a combination of bendrofluazide, hydralazine and propranolol. 2 There was a significant improvement in blood pressure control in all patients at 1 month (P less than 0.01) and this was maintained at 9 months (P less than 0.02). Tolerance to prazosin was not a problem. 3 The addition of prazosin to conventional triple drug therapy produces a further useful fall in blood pressure.Keywords
This publication has 13 references indexed in Scilit:
- Minoxidil and the Treatment of Severe HypertensionNew England Journal of Medicine, 1980
- Hydrallazine in hypertension: is there a safe dose?BMJ, 1980
- CAPTOPRIL IN THE TREATMENT OF CLINICAL HYPERTENSION AND CARDIAC FAILUREThe Lancet, 1979
- Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure.Circulation, 1979
- Development of systemic vasodilator tolerance to prazosin with chronic use of the agent in ambulatory therapy of severe congestive heart failureThe American Journal of Cardiology, 1978
- Effects of prazosin on forearm resistance and capacitance vesselsClinical Pharmacology & Therapeutics, 1977
- EVALUATION OF BETA BLOCKADE, BENDROFLUAZIDE, AND PRAZOSIN IN SEVERE HYPERTENSIONThe Lancet, 1977
- Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood PressureJAMA, 1977
- Prazosin: the first-dose phenomenon.BMJ, 1976
- Partial versus complete control of blood pressure in the prevention of hypertensive complications.Circulation Research, 1975